If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
550.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 20.00 (3.704%)
Market Cap: £90.06m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Grant of share awards

24 Mar 2022 12:57

RNS Number : 9364F
Anpario PLC
24 March 2022
 
Anpario plc("Anpario", "Group" or the "Company")

 

Grant of share awards

 

Further to the detail in the Remuneration Committee Report released as part of the Final Results announcement on 16 March 2022, Anpario announces that, on 23 March 2022, it has granted awards under a new Performance Share Plan (PSP) and the existing Joint Share Ownership Plan (JSOP) for 2022.

 

Long term incentive structure

 

Following advice from FIT Remuneration Consultants LLP and a consultation process with shareholders, Anpario plans to introduce a new long-term incentive structure that will apply to Executive Directors and management. Following a review of current market practices and considering the merits of different awards structures, Anpario has introduced a new Performance Share Plan to work alongside the existing JSOP share scheme.

 PSP Awards

 

The Anpario PSP award will create a maximum opportunity for the participating Executive Directors equivalent to 100% of salary, Executive Management 40% of salary and other key management 20% of salary.

 

As part of the awards made on 23 March 2022, the Company granted initial awards under the PSP ("Awards") over Ordinary Shares of 23 pence each in the Company ("Shares") to the following director:

 

DirectorRoleNo. of Shares under Award

Marc Wilson

Group Finance Director

26,168

The Awards have been granted in the form of nil-cost share options and will normally vest after three years, subject to the achievement of performance conditions. Awards may become exercisable subject to continued employment and the achievement of three performance conditions, being a financial target representing 75% of the total award and two further ESG components representing the remaining 25% as described below.

 

Diluted adjusted earnings per share

 

The Awards will be 75% weighted on the achievement of diluted adjusted earnings per share growth targets, the baseline for which is the equivalent figure for the year ended 31 December 2021 which was 23.01p per share. This will then be compared to the equivalent figure for the year ending 31 December 2024.

 

Target Growth % of total award that may Vest

Less than 27.41p

[equivalent to 6% growth per annum]

nil

Equal to 27.41p

18.75%

Greater than 27.41p but not less than 35.92p

Pro-rata between 18.75% and 75% on a straight-line basis

Equal to or greater than 35.92p

[equivalent to 16% growth per annum]

75%

 

ESG Objectives

 

The primary objective for ESG based targets is to reduce Carbon Intensity1 in-line with our ambitions to achieve net-zero emissions by 2030, this represents 15% of the total PSP award. The baseline for Carbon Intensity is based on the figure for the year ended 31 December 2019 of 6.17 (tCO2e per £m sales). This will then be compared to the equivalent figure for the year ending 31 December 2024 to assess the cumulative reduction in intensity for the period.

 

Target Cumulative Reduction% of total award that may Vest

Less than 63%

nil

Equal to 63%

4.5%

Greater than 63% but not less than 70%

Pro-rata between 4.5% and 15% on a straight-line basis

Equal to or greater than 70%

15%

 

1 defined as Anpario's Scope 1 and 2 carbon emissions per £m of sales (tCO2e per £m sales).

 

The final potential 10% of the PSP Award will be based on the achievement of progress towards other ESG objectives. This will be based on a qualitative assessment by the Remuneration Committee which will consider a range of quantitative and qualitative inputs, including but not limited to: diversity, equality and inclusiveness; training and development of staff; reductions in waste and water usage; health and safety; and sustainable business operations.

 

JSOP Awards

 

Anpario announces that, on 23 March 2022, it has allotted a total of 600,000 new Shares. The Ordinary Shares have been issued at a subscription price of 545 pence per Ordinary Share, being the closing price of an Ordinary Share on 22 March 2022, pursuant to The Anpario plc Employees' JSOP (the "Plan").

 

The Ordinary Shares have been issued into the respective joint beneficial ownership of (i) each of the participating individuals named below and (ii) the trustee of the Trust upon and subject to the terms of joint ownership agreements ("JOAs") respectively entered into between the Executive concerned, the Company and the Trustee. The subscription price has been paid by the Trust out of funds advanced to it by the Company.

 

Individual/Group Jointly Owned Shares Awarded

Marc Wilson

300,000

Members of the Executive Management Team

300,000

 

The terms of the JOAs provide, inter alia, that if jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners so that the participants receive an amount equal to any growth in the market value of the jointly owned Ordinary Shares above the initial market value of 545 pence per share, less a "carrying cost" (equivalent to simple interest at 4.5 per cent per annum on the initial market value) and the Trust receives the initial market value of the jointly owned shares plus the carrying cost. Jointly owned Ordinary Shares will become vested if the participant remains with the Company for a minimum period of 3 years.

 

Effect of the transactions

 

The interests of the Directors in the Ordinary shares of 23p each in the Company held before and after the above transactions, and remaining unchanged are:

 

Director Ordinary shares

Marc Wilson

9,676

 

Under the Company's long term incentive plans the rights of Directors to acquire Ordinary shares of 23p each in the Company before and after the above transactions are:

 

DirectorAward planInterests prior to the transactionsNew interests grantedInterests followingthe transactions

Marc Wilson

JSOP1

20,000

-

20,000

 

SAYE

5,577

-

5,577

 

JSOP1

50,000

-

50,000

 

PSP

-

26,168

26,1682

 

JSOP1

-

300,000

300,000

 

1 The exercise price also includes a carrying cost equivalent to simple interest at 4.5% per annum on the option price for three years

2 Vesting is conditional, this number represents the maximum potential award, subject to the achievement of financial and ESG targets as described earlier

 

An application has been made to the London Stock Exchange plc for the admission to trading on AIM of 600,000 Ordinary Shares in respect of these shares awarded under the JSOP. It is expected that admission of these new Ordinary Shares will become effective on 30 March 2022 ("Admission"). These new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares in issue.

 

Following Admission, the Company's total issued share capital is 24,276,719 Ordinary Shares. The Company holds 440,388 Ordinary Shares in Treasury. Therefore, the total number of voting rights in the Company is 23,836,331. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

 

 

Enquiries:

 

Anpario plc

Richard Edwards, CEO

+44(0) 777 6417 129

Marc Wilson, Group Finance Director

+44(0) 1909 537380

Karen Prior, Corporate Responsibility Director and Company Secretary

+44(0) 1909 537380

 

Peel Hunt LLP (Nomad and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Lalit Bose

 

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014 (as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

 

1Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Marc Wilson

2Reason for the notification

a)

Position/status

Group Finance Director

b)

Initial notification/Amendment

Initial notification

3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Anpario plc

b)

LEI

213800BZHUIUCH3MCC06

4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 23 pence each in the Company ("Ordinary Shares")

 

ISIN GB00B3NWT178

b)

Nature of the transaction

Grant of PSP options

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

nil

26,168

d)

Aggregated information

 

Price(s)

Volume(s)

nil

26,168

e)

Date of the transaction

23 March 2022

f)

Place of the transaction

Outside a trading venue

 

 

1Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Marc Wilson

2Reason for the notification

a)

Position/status

Group Finance Director

b)

Initial notification/Amendment

Initial notification

3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Anpario plc

b)

LEI

213800BZHUIUCH3MCC06

4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 23 pence each in the Company ("Ordinary Shares")

 

ISIN GB00B3NWT178

b)

Nature of the transaction

Issuance of Ordinary Shares under JSOP

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

545p

300,000

d)

Aggregated information

 

Price(s)

Volume(s)

545p

300,000

e)

Date of the transaction

23 March 2022

f)

Place of the transaction

London Stock Exchange (XLON), AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKQBPBBKDPNB
Date   Source Headline
29th Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Jun 20264:14 pmRNSHolding(s) in Company
18th Jun 202612:35 pmRNSResult of AGM
18th Jun 20267:00 amRNSAGM Statement
11th Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
28th May 20267:00 amRNSPosting of Annual Report and Notice of AGM
20th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
19th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
18th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
15th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
14th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
13th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
12th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
11th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
7th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
6th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
5th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Apr 20267:00 amRNSLaunch of Share Buyback Programme
10th Apr 202612:00 pmRNSInvestor Presentation via Investor Meet Company
31st Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSHolding(s) in Company
19th Jan 20263:44 pmRNSBlock listing return
19th Jan 20267:00 amRNSFull year trading statement
23rd Sep 20257:00 amRNSChange of Auditor
10th Sep 20257:00 amRNSInterim Results
9th Sep 202511:36 amRNSInvestor Presentation via Investor Meet Company
22nd Jul 20257:00 amRNSJSOP Awards and TVR
17th Jul 20251:15 pmRNSBlock listing return
19th Jun 20252:01 pmRNSResult of AGM
19th Jun 20257:00 amRNSAGM Statement
19th May 20255:33 pmRNSPosting of Annual Report and Notice of AGM
2nd May 20257:00 amRNSInvestor Presentation via Investor Meet Company
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSLaunch of Share Buyback Programme
2nd Apr 20257:00 amRNSAward Exercise, Voting Rights & Director Dealing
31st Mar 20257:00 amRNSFinal Results
26th Mar 20257:00 amRNSUpdate on Timing of Full Year Results Announcement
15th Jan 20257:00 amRNSGrant of options under SAYE Scheme
10th Jan 20257:00 amRNSFull year trading statement
9th Jan 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.